Approximately 5 % of the population have highly elevated levels of lipoprotein(a) (Lp(a)), which is a genetically determined risk factor for cardiovascular disease. Measuring lipoprotein(a) can improve cardiovascular risk stratification and have consequences for preventive measures. Treatment is targeted at reducing modifiable cardiovascular risk factors, but Lp(a)-lowering drugs are being trialled. This article reviews the management of lipoprotein(a) in clinical practice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4045/tidsskr.21.0800 | DOI Listing |
Publication Analysis
Top Keywords
levels lipoproteina
8
cardiovascular risk
8
high levels
4
lipoproteina
4
lipoproteina assessment
4
assessment treatment
4
treatment 5 %
4
5 % population
4
population highly
4
highly elevated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!